High Rx costs are no new thing. But pharmaceutical execs actually copping to it? It happened yesterday. In a hearing in D.C., senators grilled top executives from pharma companies about list prices of medications, some of which can be life-saving for patients.
Research continues to confirm that antibiotics and and other medicines are wreaking havoc in freshwater lakes, ponds, and rivers all around the world.
A study published in Scientific Reports suggests proton pump inhibitors (PPIs) to treat heartburn or acid reflux may increase kidney disease risk.
Drugs made from valsartan, losartan, and irbesartan purchased from suppliers in India and China have been recalled due to possible contamination.
A device that gives small electrical stimulations to the brain could eliminate the need for RA medications in some people, but will it take the disease away entirely? A rheumatology expert weighs in on vagus nerve stimulation.
Many hospitals are cutting back on the use of powerful, risky antibiotics called fluoroquinolones, but are sending patients home with these medications.
Taking emergency birth control to prevent unwanted pregnancy? Here’s how it works and what side effects you may experience.
Drug manufactueres have announced a 60 percent reduction in the U.S. prices of their cholesterol-lowering medication, Praluent (alirocumab).
Most metastatic colon cancer patients receive a combination of chemotherapy and a targeted therapy, which interrupts tumor cells’ growth and spread.
New immunotherapy drugs are helping kidney cancer patients live longer, and in some cases are leading to a complete remission of the disease.